Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry’s Interdisciplinary Prize

Posted 2025-06-25, Pharmiweb Headlines

Awarded in recognition of excellence in research and innovation and contribution to scientific progress Reflects the revolutionary potential of Curve’s gene-encoded Microcycle® platform to unlock the therapeutic potential of intracellular targets Southampton, UK, 25 June 2025 - Curve Therapeutics (“Curve” or the... read full story

Ask about this article

Answer for your question of the article will be displayed here ...

Related News

Curve Therapeutics Co-Founder and CSO Professor Ali Tavassoli awarded the Royal Society of Chemistry's Interdisciplinary Prize

PR Newswire 2025-06-25, 11:07

Oxford University researchers recognised in the 2025 Royal Society of Chemistry Prizes (University of Oxford)

Public Technologies 2025-06-25, 11:51

UK-wide research group wins prestigious Royal Society of Chemistry Prize for advancing circular economy solutions in the chemical sector (Loughborough University)

Public Technologies 2025-06-25, 14:01

Related News

King's scientist honoured with prestigious Royal Society of Chemistry prize for contribution to scientific progress (King's College London)

Public Technologies
2025-06-25, 12:54

Double Royal Society of Chemistry prize recognition for Liverpool researchers (The University of Liverpool)

Public Technologies
2025-06-25, 11:51

Professor Karen Leeder awarded 2025 Griffin Poetry Prize (University of Oxford)

Public Technologies
2025-06-26, 15:56

Mahershala Ali doesn’t know ‘where Marvel is at right now’ with Blade reboot: ‘Let them ...

FBC News
2025-06-25, 07:30

Royal Society of Chemistry changes direction on open access rollout following community feedback

Chemistry World
2025-06-25, 15:19

Appointments/reappointments to the Council of the Pharmaceutical Society of Ireland (Department of Health of Ireland)

Public Technologies
2025-06-24, 16:02

Grace Therapeutics Announces Submission of New Drug Application to U.S. Food and Drug Administration for GTx-104

Nasdaq Globe Newswire
2025-06-25, 13:48
OSZAR »